Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pd Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel palladium catalyst enables mild enamine synthesis. Reduces waste and cost for pharmaceutical intermediate manufacturing with high atom economy.
Patent CN101811973A enables high-selectivity solvent-free hydrogenation for halogenated arylamines. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Patent CN108686687B reveals novel Zn-Pd SiC catalyst for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain reliability.
Patent CN116903428B introduces CuPd catalyst for diyne synthesis offering high yield and recyclability for pharmaceutical intermediate manufacturing supply chains.
High-yield synthesis method for palladium catalyst. Reduces cost and improves supply chain reliability for pharmaceutical intermediates and fine chemical manufacturing processes.
Patent CN110124743B details a novel supported porous metal organic Pd catalyst for synthesizing 1,1,2,3,3-pentamethylindane, offering superior stability and reduced waste.
Discover the patented CN101817766A method for producing metanilic acid. Achieve 100% conversion with recyclable Pd/C catalysts, eliminating iron sludge and reducing costs for dye and pharma intermediates.
Patent CN112312902B enables direct enantioselective C-H arylation of free carboxylic acids. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN103406148A details high-activity NHC-Pd catalysts for aminocarbonylation. Discover cost-effective synthesis and scalable supply solutions for pharmaceutical intermediates.
Patent CN112679336A reveals a green heterogeneous Pd@POL catalytic route for phenylpropionic acids, offering reduced heavy metal residues and enhanced supply chain reliability for pharmaceutical intermediates.